Since 1980 the totally implantable insulin pump has been used to deliver insulin to Type I and Type II diabetic patients. A group of 30 patients has continued to use and enjoy the benefits of this pump (Infusaid Model 100). Pump safety and reliability have been excellent. The pump has functioned for 458 patient-months in this group of diabetic patients. Complications consist of one pump pocket infection, a pump plugging shortly after placement, and one pump replacement for gradual flow decrease. All pump insulin flow has been continuous and single-rate; most, but not all, of the Type I patients supplement with subcutaneous insulin, none of the Type II patients supplement. Hypoglycemia has been rare, mild, and not requiring medical attention. Hyperglycemia has been largely prevented.
|Original language||English (US)|
|Number of pages||3|
|Journal||Transactions - American Society for Artificial Internal Organs|
|State||Published - Dec 1 1984|